Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07810517) titled 'Lactobacillus Acidophilus and Inulin for Cognitive Impairment in Obesity' on Sept. 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Anahuac University
Condition:
Obesity (Disorder)
Intervention:
Dietary Supplement: Synbiotic (Lactobacillus acidophilus LA-5 and Agave Inulin)
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: November 1, 2026
Target Sample Size: 40
Countries of Recruitment:
Mexico
To know more, visit https://clinicaltria...